Form 4: ResMed Director Karen Drexler Acquires 1,083 Shares Through Restricted Stock Units

ResMed director Karen Drexler acquired 1,083 shares of common stock through the vesting of restricted stock units.

Summary

• Karen Drexler, a director at ResMed Inc., acquired 1,083 shares of ResMed common stock on November 20, 2024.
• The shares were acquired through the vesting of restricted stock units (RSUs).
• The RSUs were granted at a price of $0.
• Following the transaction, Ms. Drexler directly owns 9,529 shares of ResMed common stock.
• The RSUs cliff vest on the earlier of November 11, 2025, or the annual shareholder's meeting in the year following the grant date.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of stock-based compensation for a director, which is generally viewed neutrally to slightly positive as it aligns director interests with shareholders.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to stock-based compensation for a company director, which is common practice in publicly traded companies.

Comparison to Industry Standards

• Stock-based compensation, such as restricted stock units, is a common practice for compensating directors and executives in publicly traded companies like ResMed.
• The vesting schedule of the RSUs, with a cliff vesting date, is also a standard practice to incentivize long-term commitment and performance.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

ResMed, Director, Karen Drexler, Stock Acquisition, Restricted Stock Units, RSU, Share Ownership, Insider Trading